IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary, ...

Beta Bionics (BBNX) reported preliminary, unaudited Q4 2025 net sales of at least $32M, compared to estimate of $28.9M, ...

According to the World Stroke Organization, one-in-four people will suffer a stroke at some point in their life.

BofA analyst Travis Steed raised the firm’s price target on Beta Bionics (BBNX) to $33 from $30 and keeps a Buy rating on the shares as the firm ...

In 2024, medtech IPOs began to come back, thanks to the likes of heart valve company Anteris Technologies and neurotech ...

Beta Bionics Inc. was born out of a father’s desire to improve his son’s quality of life following a diabetes diagnosis. Today, 10 years after its founding, it’s now a publicly traded company. The ...

Ekso Bionics stock rises after non-binding term sheet with Applied Digital to merge cloud computing units into ChronoScale ...

The catalyst for Ekso's impressive stock performance was the news that Applied Digital is pursuing a separation of its cloud segment into a standalone entity. This announcement was made on a day when ...

Generative Bionics, an Italian company developing Physical AI powered humanoid robots, unveiled its first concept at CES 2026 ...

EKSO Bionics shares surged after Applied Digital agreed to spin off its cloud business and combine it with EKSO. Shares climbed 64% to $8.91 in after-hours trading Monday. Through the close, the stock ...

Advanced Bionics Corp., a medical device company controlled by Los Angeles businessman Alfred E. Mann, agreed Tuesday to be acquired by industry giant Boston Scientific Corp. Based in Valencia, ...

Thousands of steps walked, against all odds. Nine hundred and sixty four physical therapy sessions gifted to patients. More than 200,000 charitable dollars matched. Several salty tears. And one ...